EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III – Abdominal Treatment Procedures (Short Version)

C. F. Dietrich; T. Lorentzen; L. Appelbaum; E. Buscarini; V. Cantisani; J. M. Correas; X. W. Cui; M. D’Onofrio; O. H. Gilja; M. Hocke; A. Ignee; C. Jenssen; A. Kabaalioğlu; E. Leen; C. Nicolau; C. P. Nolsøe; M. Radzina; C. Serra; P. S. Sidhu; Z. Sparchez; F. Piscaglia

doi:10.1055/s-0035-1553965

Ultraschall in der Medizin - European Journal of Ultrasound, Table of Contents

Ultraschall Med 2016; 37(01): 27-45
DOI: 10.1055/s-0035-1553965

Guidelines

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III – Abdominal Treatment Procedures (Short Version)

EFSUMB Leitlinien interventioneller Ultraschall (INVUS), Teil III – Ultraschall-geführte therapeutische Interventionen (Kurzversion)

C. F. Dietrich

¹Department of Internal Medicine 2, Caritas Krankenhaus, Bad Mergentheim, Germany

⁷Sino-German Research Center of Ultrasound in Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

,

T. Lorentzen

²Department of Gastric Surgery, Ultrasound Section, Herlev Hospital, University of Copenhagen, Denmark

,

L. Appelbaum

³Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

,

E. Buscarini

⁴Department of Gastroenterology and Endoscopy, Ospedale Maggiore Crema, Italy

,

V. Cantisani

⁵Department of Radiological Sciences, Oncology and Pathology, Policlinico Umberto I, Univ. Sapienza, Rome, Italy

,

J. M. Correas

⁶Department of Adult Radiology, Paris-Descartes University and Necker University Hospital, Paris, and Institut Langevin – Inserm U979, Paris, France

,

X. W. Cui

¹Department of Internal Medicine 2, Caritas Krankenhaus, Bad Mergentheim, Germany

⁷Sino-German Research Center of Ultrasound in Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

,

M. D’Onofrio

⁸Department of Radiology, GB Rossi University Hospital, University of Verona, Italy

,

O. H. Gilja

⁹National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen Norway and Department of Clinical Medicine, University of Bergen, Norway

,

M. Hocke

¹⁰Department of Internal Medicine 2, Helios Hospital Meiningen GmbH, Meiningen, Germany

,

A. Ignee

¹Department of Internal Medicine 2, Caritas Krankenhaus, Bad Mergentheim, Germany

,

C. Jenssen

¹¹Department of Internal Medicine, Krankenhaus Märkisch Oderland Strausberg/Wriezen, Germany

,

A. Kabaalioğlu

¹²Department of Radiology, Akdeniz University Medical Faculty, Antalya, Turkey

,

E. Leen

¹³Imperial College London and Imaging Department, Hammersmith Hospital Campus, London, UK

,

C. Nicolau

¹⁴Radiology Department, Hospital Clinic, Barcelona, Spain

,

C. P. Nolsøe

²Department of Gastric Surgery, Ultrasound Section, Herlev Hospital, University of Copenhagen, Denmark

,

M. Radzina

¹⁵Diagnostic Radiology Institute, Paula Stradins Clinical University Hospital, Riga, Latvia

,

C. Serra

¹⁶Diagnostic and Interventional Ultrasound Unit, Department of Organ Failure and Transplantation, S. Orsola-Malpighi Hospital Bologna, Italy

,

P. S. Sidhu

¹⁷Department of Radiology, King's College Hospital, London, UK

,

Z. Sparchez

¹⁸Department of Gastroenterology, Institute for Gastroenterology and Hepatology, University of Medicine and Pharmacy, “Iuliu Hatieganu" Cluj-Napoca, Institute for Gastroenterology and Hepatology "O.Fodor" Cluj-Napoca, Romania

,

F. Piscaglia

¹⁹Unit of Internal Medicine, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

› Author Affiliations

Abstract

The third part of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on Interventional Ultrasound assesses the evidence for ultrasound-guided and assisted interventions in abdominal treatment procedures. Recommendations for clinical practice are presented covering indications, contraindications, safety and efficacy of the broad variety of these techniques. In particular, drainage of abscesses and fluid collections, interventional tumor ablation techniques, interventional treatment of symptomatic cysts and echinococcosis, percutaneous transhepatic cholangiography and drainage, percutaneous gastrostomy, urinary bladder drainage, and nephrostomy are addressed (short version; a long version is published online).

Zusammenfassung

Der dritte Teil der Leitlinien der European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) zur interventionellen Sonografie im Abdomen bewertet die Evidenz für transkutane sonografisch gestützte und assistierte therapeutische Interventionen im Abdomen. Auf der Grundlage publizierter Daten werden zu Indikationen, Kontraindikationen sowie zur sicheren und effizienten Durchführung Empfehlungen für die klinische Praxis gegeben. Berücksichtigung finden die sonografisch geführte Drainage von Abszessen und Flüssigkeitsansammlungen, Tumorablationstechniken, transkutane Zystensklerosierung symptomatischer Zysten und der Echinokokkose, die perkutane transhepatische Cholangiografie und Drainage, die perkutane Gastrostomie, die Harnblasenpunktion und Drainage sowie die Nephrostomie (Kurzversion; eine Langversion ist online publiziert).

Key words

guideline - ultrasound guidance - abscess - hepatocellular carcinoma - liver metastases - radiofrequency ablation - drainage - safety

Full Text

References

References
1 Lorentzen T, Nolsoe CP, Ewertsen C et al. EFSUMB Guidelines on Interventional Ultrasound, Part I: General Aspects. Ultraschall in Med 2015; 36: 464-472
2 Sidhu PS, Bradbrand K, Cantisani V et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II: Diagnostic Ultrasound Guided Interventional Procedures. Ultraschall in Med 2015; in press
3 Jenssen C, Hocke M, Fusaroli P et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV: EUS-guided Interventions: General Aspects and EUS-guided Sampling. Ultraschall in Med 2015; in press
4 Fusaroli P, Jenssen C, Hocke M et al. EFSUMB INVUS Guidelines, Part V: EUS-guided Therapeutic Interventions. Ultraschall in Med 2015; in press
5 Jenssen C, Brkljacic B, Hocke M et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part VI: Ultrasound-Guided Vascular Interventions. Ultraschall in Med 2015; in Press
6 Dietrich CF, Lorentzen T, Sidhu PS et al. An introduction into the EFSUMB guidelines on interventional ultrasound. Ultraschall in Med 2015; 36: 460-463
7 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34: 11-29
8 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
9 Dietrich CF, Cui XW, Chiorean L et al. Local ablative procedures of the liver. Z Gastroenterol 2015; 53: 579-590
10 Gillams A, Goldberg N, Ahmed M et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontieres meeting 2013. Eur Radiol 2015;
11 Dietrich CF, Albrecht T, Bernatik T et al. Lokal ablative Verfahren von Lebertumoren; Radiofrequenzablation (RFA). In: Dietrich CF, Nurnberg D, eds. Interventionelle Sonografie. Thieme Verlag; 2011: 264-282
12 Dietrich CF, Braden B, Hocke M. Lokal ablative Verfahren, Perkutane Alkoholinjektion. In: Dietrich CF, Nurnberg D, eds. Interventionelle Sonografie. Thieme Verlag; 2011: 257-263
13 Ebert MP, Auernhammer C, Caca K et al. Gastrointestinal oncology – therapy update 2008 / 2009. Z Gastroenterol 2009; 47: 296-306
14 Greten TF, Malek NP, Schmidt S et al. Diagnosis of and therapy for hepatocellular carcinoma. Z Gastroenterol 2013; 51: 1269-1326
15 Abi-Jaoudeh N, Duffy AG, Greten TF et al. Personalized oncology in interventional radiology. J Vasc Interv Radiol 2013; 24: 1083-1092
16 Vivarelli M, Guglielmi A, Ruzzenente A et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240: 102-107
17 Ruzzenente A, Guglielmi A, Sandri M et al. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 2012; 16: 301-311
18 Dietrich CF, Braden B. Perkutane Zystensklerosierung. In: Dietrich CF, Nuernberg D, eds. Interventionelle Sonografie. Thieme; 2011: 233-239
19 Carrafiello G, Lagana D, Cotta E et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol 2010; 33: 835-839
20 Mazziotti A, Grazi GL, Gardini A et al. An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg 1998; 4: 271-275
21 Ploeckinger U, Kloeppel G, Wiedenmann B et al. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 2009; 90: 349-363
22 Auernhammer CJ, Jauch KW, Hoffmann JN. Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies. Zentralbl Chir 2009; 134: 410-417
23 Atwell TD, Charboneau JW, Que FG et al. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 2005; 28: 409-421
24 Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001; 25: 693-696
25 Illing R, Gillams A. Radiofrequency ablation in the treatment of breast cancer liver metastases. Clin Oncol (R Coll Radiol) 2010; 22: 781-784
26 Solbiati L, Ahmed M, Cova L et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 2012; 265: 958-968
27 Meloni MF, Andreano A, Laeseke PF et al. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Radiology 2009; 253: 861-869
28 Nikfarjam M, Shereef S, Kimchi ET et al. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 2009; 16: 1860-1867
29 Pox C, Schmiegel W, Reinacher-Schick A. Colorectal carcinoma: what's new?. Dtsch Med Wochenschr 2012; 137: 2577-2580
30 Pox C, Aretz S, Bischoff SC et al. S3-guideline colorectal cancer version 1.0. Z Gastroenterol 2013; 51: 753-854
31 Miller G, Biernacki P, Kemeny NE et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg 2007; 205: 231-238
32 Adam R, Avisar E, Ariche A et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001; 8: 347-353
33 Abdalla EK, Vauthey JN. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?. Dig Surg 2008; 25: 421-429
34 Abdalla EK. Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. Am J Surg 2009; 197: 737-739
35 Evrard S, Poston G, Kissmeyer-Nielsen P et al. Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases. PLoS One 2014; 9: e114404
36 Livraghi T, Solbiati L, Meloni F et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003; 97: 3027-3035
37 Rossi S, Di Stasi M, Buscarini E et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995; 1: 73-81
38 Livraghi T, Goldberg SN, Lazzaroni S et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661
39 Shiina S, Teratani T, Obi S et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62: 64-68
40 Sugiura N, Takara K, Ohto M et al. Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 1983; 24: 920
41 Livraghi T, Festi D, Monti F et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309-312
42 Shiina S, Tagawa K, Niwa Y et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160: 1023-1028
43 Seki T, Wakabayashi M, Nakagawa T et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817-825
44 Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
45 Omata M, Lesmana LA, Tateishi R et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474
46 Seror O, N'Kontchou G, Ibraheem M et al. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients. Radiology 2008; 248: 288-296
47 N'Kontchou G, Mahamoudi A, Aout M et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009; 50: 1475-1483
48 Chen MH, Yang W, Yan K et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232: 260-271
49 Bale R, Widmann G, Haidu M. Stereotactic Radiofrequency Ablation. Cardiovasc Intervent Radiol 2010;
50 Sainani NI, Gervais DA, Mueller PR et al. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1, Normal findings. Am J Roentgenol 2013; 200: 184-193
51 Komorizono Y, Oketani M, Sako K et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-1262
52 Imamura J, Tateishi R, Shiina S et al. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008; 103: 3057-3062
53 Llovet JM, Vilana R, Bru C et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-1129
54 Teratani T, Yoshida H, Shiina S et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43: 1101-1108
55 Ritz JP, Lehmann K, Isbert C et al. Effectivity of laser-induced thermotherapy: in vivo comparison of arterial microembolization and complete hepatic inflow occlusion. Lasers Surg Med 2005; 36: 238-244
56 Kim SW, Rhim H, Park M et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol 2009; 10: 366-376
57 Kang TW, Rhim H, Kim EY et al. Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol 2009; 10: 34-42
58 Head HW, Dodd III GD, Dalrymple NC et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 2007; 243: 877-884
59 Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825
60 Wang Y, Luo Q, Li Y et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PLoS One 2014; 9: e84484
61 Goldberg SN, Kamel IR, Kruskal JB et al. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 2002; 179: 93-101
62 Shirato K, Morimoto M, Tomita N et al. Small hepatocellular carcinoma: therapeutic effectiveness of percutaneous radio frequency ablation therapy with a LeVeen needle electrode. J Ultrasound Med 2002; 21: 67-76
63 Rossi S, Buscarini E, Garbagnati F et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998; 170: 1015-1022
64 Cucchetti A, Piscaglia F, Cescon M et al. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19: 4106-4118
65 Weis S, Franke A, Mossner J et al. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev 2013; 12: CD003046
66 Cucchetti A, Piscaglia F, Cescon M et al. An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Dig Liver Dis 2014; 46: 257-263
67 Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234: 961-967
68 Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-1209
69 Cabassa P, Donato F, Simeone F et al. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. Am J Roentgenol 2006; 186: S316-S321
70 Livraghi T, Meloni F, Di Stasi M et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?. Hepatology 2008; 47: 82-89
71 Yan K, Chen MH, Yang W et al. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 2008; 67: 336-347
72 Kasugai H, Osaki Y, Oka H et al. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3891 ablations in 2614 patients. Oncology 2007; 72: 72-75
73 Shiina S, Tagawa K, Unuma T et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991; 68: 1524-1530
74 Sung YM, Choi D, Lim HK et al. Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea. Korean J Radiol 2006; 7: 187-192
75 Livraghi T, Giorgio A, Marin G et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101-108
76 Dietrich CF, Hocke M, Jenssen C. Ultrasound for abdominal lymphadenopathy. Dtsch Med Wochenschr 2013; 138: 1001-1018
77 Brunello F, Veltri A, Carucci P et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol 2008; 43: 727-735
78 Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240
79 Lin SM, Lin CJ, Lin CC et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156
80 Shiina S, Teratani T, Obi S et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130
81 Lin SM, Lin CJ, Lin CC et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127: 1714-1723
82 Orlando A, Leandro G, Olivo M et al. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009; 104: 514-524
83 Yang B, Zan RY, Wang SY et al. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials. World J Surg Oncol 2015; 13: 96
84 Cho YK, Kim JK, Kim MY et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49: 453-459
85 Giorgio A, Di Sarno A, De Stefano G et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial. Anticancer Res 2011; 31: 2291-2295
86 Germani G, Pleguezuelo M, Gurusamy K et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol 2010; 52: 380-388
87 Bouza C, Lopez-Cuadrado T, Alcazar R et al. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009; 9: 31
88 Omata M, Tateishi R, Yoshida H et al. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127: S159-S166
89 Sala M, Llovet JM, Vilana R et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 1352-1360
90 Guglielmi A, Ruzzenente A, Valdegamberi A et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008; 12: 192-198
91 Liang P, Dong B, Yu X et al. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005; 235: 299-307
92 Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007; 72: 124-131
93 Liang P, Wang Y, Yu X et al. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology 2009; 251: 933-940
94 Lu MD, Xu HX, Xie XY et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005; 40: 1054-1060
95 Ohmoto K, Miyake I, Tsuduki M et al. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 2894-2900
96 Sato M, Watanabe Y, Ueda S et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996; 110: 1507-1514
97 Yin XY, Xie XY, Lu MD et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 2009; 115: 1914-1923
98 Ebara M, Okabe S, Kita K et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 458-464
99 Khan KN, Yatsuhashi H, Yamasaki K et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000; 32: 269-278
100 Koda M, Murawaki Y, Mitsuda A et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000; 88: 529-537
101 Pompili M, Rapaccini GL, Covino M et al. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001; 92: 126-135
102 Kim YJ, Lee MW, Park HS. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation. Abdom Imaging 2013; 38: 98-111
103 Rajesh S, Mukund A, Arora A et al. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma. J Vasc Interv Radiol 2013; 24: 1235-1240
104 Choi D, Lim HK, Lee WJ et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003; 22: 1163-1172
105 Minami Y, Kudo M, Chung H et al. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. Am J Roentgenol 2007; 188: 489-494
106 Takaki H, Yamakado K, Nakatsuka A et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. Am J Roentgenol 2013; 200: 658-664
107 Evrard S, Brouste V, McKelvie-Sebileau P et al. Liver metastases in close contact to hepatic veins ablated under vascular exclusion. Eur J Surg Oncol 2013; 39: 1400-1406
108 Desolneux G, Vara J, Razafindratsira T et al. Patterns of complications following intraoperative radiofrequency ablation for liver metastases. HPB (Oxford) 2014; 16: 1002-1008
109 Schwartz A, Desolneux G, Desjardin M et al. Symptomatic diaphragmatic hernia after pulmonary radiofrequency ablation. J Visc Surg 2013; 150: 157-158
110 Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001; 6: 14-23
111 Livraghi T, Solbiati L, Meloni MF et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-451
112 de Baère T, Risse O, Kuoch V et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003; 181: 695-700
113 Jenssen C, Dietrich CF. Kontraindikationen, Komplikationen, Komplikationsmanagment. In: Dietrich CF, Nuernberg D, eds. Interventionelle Sonografie. Thieme Verlag; 2011: 127-160
114 Arienti V, Pretolani S, Goldberg SN et al. How to report and compare complications of image-guided ablation therapies: comments on seeding and the use of a sole common denominator for liver tumors. Radiology 2006; 241: 625-626
115 Chang S, Kim SH, Lim HK et al. Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas: lessons learned from a 10-year experience. Korean J Radiol 2008; 9: 268-274
116 Livraghi T, Lazzaroni S, Meloni F et al. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-858
117 Bolondi L, Gaiani S, Celli N et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 608-601
118 Kanas GP, Taylor A, Primrose JN et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4: 283-301
119 Bradley AL, Chapman WC, Wright JK et al. Surgical experience with hepatic colorectal metastasis. Am Surg 1999; 65: 560-566
120 Doci R, Gennari L, Bignami P et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991; 78: 797-801
121 Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318
122 Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg 1998; 22: 268-276
123 Scheele J, Stangl R, Altendorf-Hofmann A et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29
124 Wagner JS, Adson MA, Van Heerden JA et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508
125 Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int 2010; 107: 335-342
126 Park IJ, Kim HC, Yu CS et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15: 227-232
127 Lorentzen T, Skjoldbye BO, Nolsoe CP. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall in Med 2011; 32: 492-496
128 Cho YK, Kim JK, Kim WT et al. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010; 51: 1284-1290
129 Lee WS, Yun SH, Chun HK et al. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 2008; 42: 945-949
130 Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213
131 Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004; 14: 2261-2267
132 Knudsen AR, Kannerup AS, Mortensen FV et al. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy. Acta Radiol 2009; 50: 716-721
133 Tanis E, Nordlinger B, Mauer M et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer 2014; 50: 912-919
134 Weng M, Zhang Y, Zhou D et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One 2012; 7: e45493
135 Bai H, Huangz X, Jing L et al. The effect of radiofrequency ablation vs. liver resection on survival outcome of colorectal liver metastases (CRLM): a meta-analysis. Hepatogastroenterology 2015; 62: 373-377
136 Ruers T, Punt C, van Coevorden F et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol 2012; 23: 2619-2626
137 Remzi M, Javadli E, Ozsoy M. Management of small renal masses: a review. World J Urol 2010; 28: 275-281
138 Aron M, Gill IS. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy. Eur Urol 2007; 51: 348-357
139 Nahum GS, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities--part I. J Vasc Interv Radiol 2001; 12: 1021-1032
140 Gervais DA, McGovern FJ, Arellano RS et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 2005; 185: 64-71
141 Gervais DA, Arellano RS, McGovern FJ et al. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. Am J Roentgenol 2005; 185: 72-80
142 Tracy CR, Raman JD, Donnally C et al. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116: 3135-3142
143 Zagoria RJ, Traver MA, Werle DM et al. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol 2007; 189: 429-436
144 Breen DJ, Rutherford EE, Stedman B et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol 2007; 30: 936-942
145 Levinson AW, Su LM, Agarwal D et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180: 499-504
146 Stein RJ, Kaouk JH. Renal cryotherapy: a detailed review including a 5-year follow-up. BJU Int 2007; 99: 1265-1270
147 Atwell TD, Callstrom MR, Farrell MA et al. Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol 2010; 184: 1291-1295
148 Atwell TD, Farrell MA, Callstrom MR et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. Am J Roentgenol 2007; 188: 1195-1200
149 Klatte T, Kroeger N, Zimmermann U et al. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol 2014; 32: 597-605
150 El DibR, Touma NJ, Kapoor A. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int 2012; 110: 510-516
151 Goel RK, Kaouk JH. Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation. Curr Opin Urol 2008; 18: 467-473
152 Wah TM, Irving HC, Gregory W et al. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 2014; 113: 416-428
153 Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20: S377-S390
154 Campbell SC, Novick AC, Belldegrun A et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271-1279
155 Psutka SP, Feldman AS, McDougal WS et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63: 486-492
156 Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol 2008; 179: 1227-1233
157 Ljungberg B, Cowan NC, Hanbury DC et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398-406
158 Meloni MF, Bertolotto M, Alberzoni C et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. Am J Roentgenol 2008; 191: 1233-1238
159 Kong WT, Zhang WW, Guo HQ et al. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?. Abdom Imaging 2011; 36: 342-347
160 Ignee A, Straub B, Brix D et al. The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. Clin Hemorheol Microcirc 2010; 46: 275-290
161 Ignee A, Straub B, Schuessler G et al. Contrast enhanced ultrasound of renal masses. World J Radiol 2010; 2: 15-31
162 Smith EH, Bartrum Jr RJ. Ultrasonically guided percutaneous aspiration of abscesses. Am J Roentgenol Radium Ther Nucl Med 1974; 122: 308-312
163 Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg 1996; 224: 10-18
164 Kishina M, Koda M, Tokunaga S et al. Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound. Hepatol Res 2014;
165 Liu GJ, Lu MD, Xie XY et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med 2008; 27: 657-666
166 Cai YL, Xiong XZ, Lu J et al. Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: a systematic review and meta-analysis. HPB (Oxford) 2014;
167 Zerem E, Hadzic A. Sonographically guided percutaneous catheter drainage versus needle aspiration in the management of pyogenic liver abscess. Am J Roentgenol 2007; 189: W138-W142
168 Zerem E, Bergsland J. Ultrasound guided percutaneous treatment for splenic abscesses: the significance in treatment of critically ill patients. World J Gastroenterol 2006; 12: 7341-7345
169 Lorentzen T, Nolsoe C, Skjoldbye B. Ultrasound-guided drainage of deep pelvic abscesses: experience with 33 cases. Ultrasound Med Biol 2011; 37: 723-728
170 Schwerk WB, Gorg C, Gorg K et al. Percutaneous drainage of liver and splenic abscess. Z Gastroenterol 1991; 29: 146-152
171 Schwerk WB, Gorg C, Gorg K et al. Ultrasound-guided percutaneous drainage of pyogenic splenic abscesses. J Clin Ultrasound 1994; 22: 161-166
172 Rothlin MA, Schob O, Klotz H et al. Percutaneous drainage of abdominal abscesses: are large-bore catheters necessary?. Eur J Surg 1998; 164: 419-424
173 Cui XW, Ignee A, Dietrich CF. Ultrasound-guided percutaneous abscess drainage. In. http://www.efsumb.org/asp/detail06.asp?ref=373&url=/intro/home.asp?ref=1: European Federation of Societies for Ultrasound in Medicine and Biology; 2011
174 Ignee A, Schuessler G, Cui XW et al. Intracavitary contrast medium ultrasound – different applications, a review of the literature ad future prospects. Ultraschall in Med 2013; 34: 504-525 ; quiz 526–508
175 Ignee A, Jenssen C, Cui XW et al. Intracavitary contrast-enhanced ultrasound in abscess drainage – feasibility and clinical value. Scand J Gastroenterol 2015; 1-7
176 Pham Van L, Duong Manh H, Pham Nhu H. Amebic abscess of the liver: ultrasound guided puncture. Ann Chir 1996; 50: 340-343
177 McInnes MD, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology 2011; 260: 699-708
178 Feagins LA, Holubar SD, Kane SV et al. Current strategies in the management of intra-abdominal abscesses in Crohn's disease. Clin Gastroenterol Hepatol 2011; 9: 842-850
179 Gervais DA, Hahn PF, O'Neill MJ et al. Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology 2002; 222: 645-651
180 Golfieri R, Cappelli A, Giampalma E et al. CT-guided percutaneous pelvic abscess drainage in Crohn's disease. Tech Coloproctol 2006; 10: 99-105
181 Sahai A, Belair M, Gianfelice D et al. Percutaneous drainage of intra-abdominal abscesses in Crohn's disease: short and long-term outcome. Am J Gastroenterol 1997; 92: 275-278
182 da Luz Moreira A, Stocchi L, Tan E et al. Outcomes of Crohn's disease presenting with abdominopelvic abscess. Dis Colon Rectum 2009; 52: 906-912
183 Rypens F, Dubois J, Garel L et al. Percutaneous drainage of abdominal abscesses in pediatric Crohn's disease. Am J Roentgenol 2007; 188: 579-585
184 Bahadursingh AM, Virgo KS, Kaminski DL et al. Spectrum of disease and outcome of complicated diverticular disease. Am J Surg 2003; 186: 696-701
185 Siewert B, Tye G, Kruskal J et al. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. Am J Roentgenol 2006; 186: 680-686
186 Brandt D, Gervaz P, Durmishi Y et al. Percutaneous CT scan-guided drainage vs. antibiotherapy alone for Hinchey II diverticulitis: a case-control study. Dis Colon Rectum 2006; 49: 1533-1538
187 Kumar RR, Kim JT, Haukoos JS et al. Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage. Dis Colon Rectum 2006; 49: 183-189
188 Kaiser AM, Jiang JK, Lake JP et al. The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 2005; 100: 910-917
189 Durmishi Y, Gervaz P, Brandt D et al. Results from percutaneous drainage of Hinchey stage II diverticulitis guided by computed tomography scan. Surg Endosc 2006; 20: 1129-1133
190 Kuligowska E, Keller E, Ferrucci JT. Treatment of pelvic abscesses: value of one-step sonographically guided transrectal needle aspiration and lavage. Am J Roentgenol 1995; 164: 201-206
191 Wroblicka JT, Kuligowska E. One-step needle aspiration and lavage for the treatment of abdominal and pelvic abscesses. Am J Roentgenol 1998; 170: 1197-1203
192 Fusaroli P, Jenssen C, Hocke M et al. EFSUMB guidelines on interventional ultrasound, part V. EUS-guided therapeutic interventions. Ultraschall in Med 2015; 36
193 Mercaldi CJ, Lanes SF. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. Chest 2013; 143: 532-538
194 Sharzehi K, Jain V, Naveed A et al. Hemorrhagic complications of paracentesis: a systematic review of the literature. Gastroenterol Res Pract 2014; 2014: 985141
195 Cervini P, Hesley GK, Thompson RL et al. Incidence of infectious complications after an ultrasound-guided intervention. Am J Roentgenol 2010; 195: 846-850
196 Cavanna L, Mordenti P, Berte R et al. Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer. World J Surg Oncol 2014; 12: 139
197 Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg 2012; 4: 87-95
198 Zerem E, Imamovic G, Omerovic S. Percutaneous treatment of symptomatic non-parasitic benign liver cysts: single-session alcohol sclerotherapy versus prolonged catheter drainage with negative pressure. Eur Radiol 2008; 18: 400-406
199 Dietrich CF, Braden B. Percutaneous Sclerotherapy of Cysts. In: Dietrich CF, Nuernberg D, eds. Interventional ultrasound. Stuttgart: Georg Thieme Verlag /Thieme Publisher; 2014: 165-166
200 Garber S, Mathieson J, Cooperberg PL. Percutaneous sclerosis of hepatic cysts to treat obstructive jaundice in a patient with polycystic liver disease. Am J Roentgenol 1993; 161: 77-78
201 Erdogan D, van Delden OM, Rauws EA et al. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease. World J Gastroenterol 2007; 13: 3095-3100
202 Benzimra J, Ronot M, Fuks D et al. Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease. Eur Radiol 2014; 24: 1030-1038
203 Gevers TJ, Drenth JP. Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol Hepatol 2013; 10: 101-108
204 Temmerman F, Missiaen L, Bammens B et al. Systematic review: the pathophysiology and management of polycystic liver disease. Aliment Pharmacol Ther 2011; 34: 702-713
205 Macutkiewicz C, Plastow R, Chrispijn M et al. Complications arising in simple and polycystic liver cysts. World J Hepatol 2012; 4: 406-411
206 Fong ZV, Wolf AM, Doria C et al. Hemorrhagic hepatic cyst: report of a case and review of the literature with emphasis on clinical approach and management. J Gastrointest Surg 2012; 16: 1782-1789
207 Furuta T, Yoshida Y, Saku M et al. Treatment of symptomatic non-parasitic liver cysts--surgical treatment versus alcohol injection therapy. HPB Surg 1990; 2: 269-277 ; discussion 277–269
208 Drenth JP, Chrispijn M, Nagorney DM et al. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010; 52: 2223-2230
209 Moorthy K, Mihssin N, Houghton PW. The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 2001; 83: 409-414
210 Yang CF, Liang HL, Pan HB et al. Single-session prolonged alcohol-retention sclerotherapy for large hepatic cysts. Am J Roentgenol 2006; 187: 940-943
211 Fabrizzi G, Lanza C, Bolli V et al. Symptomatic hepatic cyst in a child: treatment with single-shot injection of tetracycline hydrochloride. Pediatr Radiol 2009; 39: 1091-1094
212 Yoshida H, Onda M, Tajiri T et al. Long-term results of multiple minocycline hydrochloride injections for the treatment of symptomatic solitary hepatic cyst. J Gastroenterol Hepatol 2003; 18: 595-598
213 Jusufovic R, Zerem E. Percutaneous treatment of symptomatic non-parasitic benign liver cysts with 20% NaCl solution. Med Arh 2011; 65: 35-37
214 Yamamoto K, Sakaguchi H, Anai H et al. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience. Cardiovasc Intervent Radiol 2005; 28: 751-755
215 Sparchez Z, Radu P, Zaharie F et al. Percutaneous treatment of symptomatic non-parasitic hepatic cysts. Initial experience with single-session sclerotherapy with polidocanol. Med Ultrason 2014; 16: 222-228
216 vanSonnenberg E, Wroblicka JT, D'Agostino HB et al. Symptomatic hepatic cysts: percutaneous drainage and sclerosis. Radiology 1994; 190: 387-392
217 Tikkakoski T, Makela JT, Leinonen S et al. Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vasc Interv Radiol 1996; 7: 235-239
218 Larssen TB, Jensen DK, Viste A et al. Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts. Long-term results. Acta Radiol 1999; 40: 636-638
219 Larssen TB, Rosendahl K, Horn A et al. Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts performed with a time of exposure to alcohol of 10 min: initial results. Eur Radiol 2003; 13: 2627-2632
220 Skolarikos A, Laguna MP, de la Rosette JJ. Conservative and radiological management of simple renal cysts: a comprehensive review. BJU Int 2012; 110: 170-178
221 Okeke AA, Mitchelmore AE, Keeley FX et al. A comparison of aspiration and sclerotherapy with laparoscopic de-roofing in the management of symptomatic simple renal cysts. BJU Int 2003; 92: 610-613
222 Ohta S, Fujishiro Y, Fuse H. Polidocanol sclerotherapy for simple renal cysts. Urol Int 1997; 58: 145-147
223 Yoo KH, Lee SJ, Jeon SH. Simple renal cyst sclerotherapy with acetic acid: our 10-year experience. J Endourol 2008; 22: 2559-2563
224 Madeb R, Feldman PA, Knopf J et al. Povidone-iodine sclerotherapy is ineffective in the treatment of symptomatic renal cysts. J Endourol 2006; 20: 402-404
225 Kilinc M, Tufan O, Guven S et al. Percutaneous injection sclerotherapy with tetracycline hydrochloride in simple renal cysts. Int Urol Nephrol 2008; 40: 609-613
226 Ohkawa M, Tokunaga S, Orito M et al. Percutaneous injection sclerotherapy with minocycline hydrochloride for simple renal cysts. Int Urol Nephrol 1993; 25: 37-43
227 Zerem E, Imamovic G, Omerovic S. Symptomatic simple renal cyst: comparison of continuous negative-pressure catheter drainage and single-session alcohol sclerotherapy. Am J Roentgenol 2008; 190: 1193-1197
228 Mohsen T, Gomha MA. Treatment of symptomatic simple renal cysts by percutaneous aspiration and ethanol sclerotherapy. BJU Int 2005; 96: 1369-1372
229 Delakas D, Karyotis I, Loumbakis P et al. Long-term results after percutaneous minimally invasive procedure treatment of symptomatic simple renal cysts. Int Urol Nephrol 2001; 32: 321-326
230 Chung BH, Kim JH, Hong CH et al. Comparison of single and multiple sessions of percutaneous sclerotherapy for simple renal cyst. BJU Int 2000; 85: 626-627
231 Fontana D, Porpiglia F, Morra I et al. Treatment of simple renal cysts by percutaneous drainage with three repeated alcohol injection. Urology 1999; 53: 904-907
232 Hanna RM, Dahniya MH. Aspiration and sclerotherapy of symptomatic simple renal cysts: value of two injections of a sclerosing agent. Am J Roentgenol 1996; 167: 781-783
233 Egilmez H, Gok V, Oztoprak I et al. Comparison of CT-guided sclerotherapy with using 95% ethanol and 20% hypertonic saline for managing simple renal cyst. Korean J Radiol 2007; 8: 512-519
234 McManus DP, Zhang W, Li J et al. Echinococcosis. Lancet 2003; 362: 1295-1304
235 Stojkovic M, Rosenberger K, Kauczor HU et al. Diagnosing and staging of cystic echinococcosis: how do CT and MRI perform in comparison to ultrasound?. PLoS Negl Trop Dis 2012; 6: e1880
236 Brunetti E, Kern P, Vuitton DA et al. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114: 1-16
237 Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ 1996; 74: 231-242
238 Group WHOIW. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop 2003; 85: 253-261
239 Khuroo MS, Wani NA, Javid G et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997; 337: 881-887
240 Gharbi HA, Hassine W, Brauner MW et al. Ultrasound examination of the hydatic liver. Radiology 1981; 139: 459-463
241 Ben Amor N, Gargouri M, Gharbi HA et al. Trial therapy of inoperable abdominal hydatid cysts by puncture. Ann Parasitol Hum Comp 1986; 61: 689-692
242 Gargouri M, Ben Amor N, Ben Chehida F et al. Percutaneous treatment of hydatid cysts (Echinococcus granulosus). Cardiovasc Intervent Radiol 1990; 13: 169-173
243 Zhang W, Li J, McManus DP. Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev 2003; 16: 18-36
244 Rinaldi F, Brunetti E, Neumayr A et al. Cystic echinococcosis of the liver: A primer for hepatologists. World J Hepatol 2014; 6: 293-305
245 Junghanss T, da Silva AM, Horton J et al. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 2008; 79: 301-311
246 Giorgio A, de Stefano G, Esposito V et al. Long-term results of percutaneous treatment of hydatid liver cysts: a single center 17 years experience. Infection 2008; 36: 256-261
247 Akhan O, Yildiz AE, Akinci D et al. Is the adjuvant albendazole treatment really needed with PAIR in the management of liver hydatid cysts? A prospective, randomized trial with short-term follow-up results. Cardiovasc Intervent Radiol 2014; 37: 1568-1574
248 Brunetti E, Junghanss T. Update on cystic hydatid disease. Curr Opin Infect Dis 2009; 22: 497-502
249 Kabaalioglu A, Ceken K, Alimoglu E et al. Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice?. Eur J Radiol 2006; 59: 65-73
250 Dietrich CF, Nuernberg D. Interventional Ultrasound: A Practical Guide and Atlas. Stuttgart, New York, Delhi, Rio: Thieme publisher; 2014
251 Giorgio A, Tarantino L, de Stefano G et al. Hydatid liver cyst: an 11-year experience of treatment with percutaneous aspiration and ethanol injection. J Ultrasound Med 2001; 20: 729-738
252 Giorgio A, Di Sarno A, de Stefano G et al. Sonography and clinical outcome of viable hydatid liver cysts treated with double percutaneous aspiration and ethanol injection as first-line therapy: efficacy and long-term follow-up. Am J Roentgenol 2009; 193: W186-W192
253 Khuroo MS, Dar MY, Yattoo GN et al. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology 1993; 104: 1452-1459
254 Nasseri-Moghaddam S, Abrishami A, Taefi A et al. Percutaneous needle aspiration, injection, and re-aspiration with or without benzimidazole coverage for uncomplicated hepatic hydatid cysts. Cochrane Database Syst Rev 2011; CD003623
255 Gupta N, Javed A, Puri S et al. Hepatic hydatid: PAIR, drain or resect?. J Gastrointest Surg 2011; 15: 1829-1836
256 Smego Jr RA, Bhatti S, Khaliq AA et al. Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. Clin Infect Dis 2003; 37: 1073-1083
257 Cozzi G, Severini A, Civelli E et al. Percutaneous transhepatic biliary drainage in the management of postsurgical biliary leaks in patients with nondilated intrahepatic bile ducts. Cardiovasc Intervent Radiol 2006; 29: 380-388
258 Nagino M, Takada T, Miyazaki M et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008; 15: 25-30
259 Kavanagh PV, vanSonnenberg E, Wittich GR et al. Interventional radiology of the biliary tract. Endoscopy 1997; 29: 570-576
260 Adler DG, Baron TH, Davila RE et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005; 62: 1-8
261 Itoi T, Tsuyuguchi T, Takada T et al. TG13 indications and techniques for biliary drainage in acute cholangitis (with videos). J Hepatobiliary Pancreat Sci 2013; 20: 71-80
262 Skinner M, Popa D, Neumann H et al. ERCP with the overtube-assisted enteroscopy technique: a systematic review. Endoscopy 2014; 46: 560-572
263 Kuhn JP, Busemann A, Lerch MM et al. Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts compared with patients with dilated intrahepatic bile ducts. Am J Roentgenol 2010; 195: 851-857
264 Weber A, Gaa J, Rosca B et al. Complications of percutaneous transhepatic biliary drainage in patients with dilated and nondilated intrahepatic bile ducts. Eur J Radiol 2009; 72: 412-417
265 Lee W, Kim GC, Kim JY et al. Ultrasound and fluoroscopy guided percutaneous transhepatic biliary drainage in patients with nondilated bile ducts. Abdom Imaging 2008; 33: 555-559
266 Hayashi N, Sakai T, Kitagawa M et al. US-guided left-sided biliary drainage: nine-year experience. Radiology 1997; 204: 119-122
267 Miyazaki M, Shibuya K, Tokue H et al. Percutaneous transhepatic biliary drainage assisted by real-time virtual sonography: a retrospective study. BMC Gastroenterol 2013; 13: 127
268 Feigenbaum K, Ellett ML, Miller R et al. ALARA study of teaching effectiveness on reducing radiation exposure. Gastroenterol Nurs 1998; 21: 234-238
269 Gurusamy K, Junnarkar S, Farouk M et al. Meta-analysis of randomized controlled trials on the safety and effectiveness of day-case laparoscopic cholecystectomy. Br J Surg 2008; 95: 161-168
270 Gurusamy K, Samraj K, Gluud C et al. Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2010; 97: 141-150
271 Houghton PW, Jenkinson LR, Donaldson LA. Cholecystectomy in the elderly: a prospective study. Br J Surg 1985; 72: 220-222
272 Sanjay P, Mittapalli D, Marioud A et al. Clinical outcomes of a percutaneous cholecystostomy for acute cholecystitis: a multicentre analysis. HPB (Oxford) 2013; 15: 511-516
273 Winbladh A, Gullstrand P, Svanvik J et al. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford) 2009; 11: 183-193
274 Johanning JM, Gruenberg JC. The changing face of cholecystectomy. Am Surg 1998; 64: 643-647 ; discussion 647–648
275 Barie PS, Eachempati SR. Acute acalculous cholecystitis. Curr Gastroenterol Rep 2003; 5: 302-309
276 Simorov A, Ranade A, Parcells J et al. Emergent cholecystostomy is superior to open cholecystectomy in extremely ill patients with acalculous cholecystitis: a large multicenter outcome study. Am J Surg 2013; 206: 935-940 ; discussion 940–931
277 Chung YH, Choi ER, Kim KM et al. Can percutaneous cholecystostomy be a definitive management for acute acalculous cholecystitis?. J Clin Gastroenterol 2012; 46: 216-219
278 Kirkegard J, Horn T, Christensen SD et al. Percutaneous Cholecystostomy is an Effective Definitive Treatment Option for Acute Acalculous Cholecystitis. Scand J Surg 2015;
279 Melloul E, Denys A, Demartines N et al. Percutaneous drainage versus emergency cholecystectomy for the treatment of acute cholecystitis in critically ill patients: does it matter?. World J Surg 2011; 35: 826-833
280 Hatjidakis AA, Karampekios S, Prassopoulos P et al. Maturation of the tract after percutaneous cholecystostomy with regard to the access route. Cardiovasc Intervent Radiol 1998; 21: 36-40
281 Venara A, Carretier V, Lebigot J et al. Technique and indications of percutaneous cholecystostomy in the management of cholecystitis in 2014. J Visc Surg 2014; 151: 435-439
282 van Overhagen H, Meyers H, Tilanus HW et al. Percutaneous cholecystectomy for patients with acute cholecystitis and an increased surgical risk. Cardiovasc Intervent Radiol 1996; 19: 72-76
283 Loberant N, Notes Y, Eitan A et al. Comparison of early outcome from transperitoneal versus transhepatic percutaneous cholecystostomy. Hepatogastroenterology 2010; 57: 12-17
284 Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev 2013; 11: CD005571
285 Lowe AS, Laasch HU, Stephenson S et al. Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol 2012; 67: 843-854
286 Wah TM, Weston MJ, Irving HC. Percutaneous nephrostomy insertion: outcome data from a prospective multi-operator study at a UK training centre. Clin Radiol 2004; 59: 255-261
287 Hausegger KA, Portugaller HR. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications. Eur Radiol 2006; 16: 2016-2030
288 Mahmood RD, Yizhi L, Tan MLM. Percutaneous Nephrostomy. In: Goeoz M, ed. Chronic Kidney Disease. InTech; 2012: 297-314
289 Ramchandani P, Cardella JF, Grassi CJ et al. Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol 2003; 14: S277-S281
290 Dagli M, Ramchandani P. Percutaneous nephrostomy: technical aspects and indications. Semin Intervent Radiol 2011; 28: 424-437
291 Png JC, Chapple CR. Principles of ureteric reconstruction. Curr Opin Urol 2000; 10: 207-212
292 Lapitan MC, Buckley BS. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort. J Obstet Gynaecol Res 2011; 37: 1061-1070
293 Ahmad I, Saeed Pansota M, Tariq M et al. Comparison between Double J (DJ) Ureteral Stenting and Percutaneous Nephrostomy (PCN) in Obstructive Uropathy. Pak J Med Sci 2013; 29: 725-729
294 Wyatt J, Kolettis PN, Burns JR. Treatment outcomes for percutaneous nephrolithotomy in renal allografts. J Endourol 2009; 23: 1821-1824
295 Mahdavi R, Tavakkoli M, Taghavi R et al. Minimally invasive procedures for treatment of urolithiasis in transplanted kidneys. Exp Clin Transplant 2014; 12: 200-204
296 Farrell TA, Hicks ME. A review of radiologically guided percutaneous nephrostomies in 303 patients. J Vasc Interv Radiol 1997; 8: 769-774
297 Skolarikos A, Alivizatos G, Papatsoris A et al. Ultrasound-guided percutaneous nephrostomy performed by urologists: 10-year experience. Urology 2006; 68: 495-499
298 Kariniemi J, Sequeiros RB, Ojala R et al. MRI-guided percutaneous nephrostomy: a feasibility study. Eur Radiol 2009; 19: 1296-1301
299 Barbaric ZL, Hall T, Cochran ST et al. Percutaneous nephrostomy: placement under CT and fluoroscopy guidance. Am J Roentgenol 1997; 169: 151-155
300 Ray Jr CE, Brown AC, Smith MT et al. Percutaneous access of nondilated renal collecting systems. Semin Intervent Radiol 2014; 31: 98-100
301 Patel U, Hussain FF. Percutaneous nephrostomy of nondilated renal collecting systems with fluoroscopic guidance: technique and results. Radiology 2004; 233: 226-233
302 Fischbach F, Porsch M, Krenzien F et al. MR imaging guided percutaneous nephrostomy using a 1.0 Tesla open MR scanner. Cardiovasc Intervent Radiol 2011; 34: 857-863
303 Cui XW, Ignee A, Maros T et al. The use of ultrasound contrast agent in ultrasound guided percutaneous nephrostomy. In: Lepzig: Z Gastroenterol; 2014: KG264
304 Karim R, Sengupta S, Samanta S et al. Percutaneous nephrostomy by direct puncture technique: An observational study. Indian J Nephrol 2010; 20: 84-88
305 Regalado SP. Emergency percutaneous nephrostomy. Semin Intervent Radiol 2006; 23: 287-294
306 Cangüven O, Göktafl C, Kafkasl A et al. Comparison of direct and Seldinger percutaneous nephrostomy insertion techniques. BTDMJB 2009; 5: 103-105
307 Dyer RB, Regan JD, Kavanagh PV et al. Percutaneous nephrostomy with extensions of the technique: step by step. Radiographics 2002; 22: 503-525
308 Radecka E, Magnusson A. Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol 2004; 45: 184-188
309 LeMaitre L, Mestdagh P, Marecaux-Delomez J et al. Percutaneous nephrostomy: placement under laser guidance and real-time CT fluoroscopy. Eur Radiol 2000; 10: 892-895
310 Lee MJ, Papanicolaou N, Nocks BN et al. Fluoroscopically guided percutaneous suprapubic cystostomy for long-term bladder drainage: an alternative to surgical cystostomy. Radiology 1993; 188: 787-789
311 Gochman RF, Karasic RB, Heller MB. Use of portable ultrasound to assist urine collection by suprapubic aspiration. Ann Emerg Med 1991; 20: 631-635
312 Chu RW, Wong YC, Luk SH et al. Comparing suprapubic urine aspiration under real-time ultrasound guidance with conventional blind aspiration. Acta Paediatr 2002; 91: 512-516
313 Kiernan SC, Pinckert TL, Keszler M. Ultrasound guidance of suprapubic bladder aspiration in neonates. J Pediatr 1993; 123: 789-791
314 Cronin CG, Prakash P, Gervais DA et al. Imaging-guided suprapubic bladder tube insertion: experience in the care of 549 patients. Am J Roentgenol 2011; 196: 182-188
315 Jacob P, Rai BP, Todd AW. Suprapubic catheter insertion using an ultrasound-guided technique and literature review. BJU Int 2012; 110: 779-784
316 Lawrentschuk N, Lee D, Marriott P et al. Suprapubic stab cystostomy: a safer technique. Urology 2003; 62: 932-934
317 Aguilera PA, Choi T, Durham BA. Ultrasound-guided suprapubic cystostomy catheter placement in the emergency department. J Emerg Med 2004; 26: 319-321
318 Lamont T, Harrison S, Panesar S et al. Safer insertion of suprapubic catheters: summary of a safety report from the National Patient Safety Agency. BMJ 2011; 342: d924
319 Johnson S, Fiscus G, Sudakoff GS et al. The utility of abdominal ultrasound during percutaneous suprapubic catheter placement. Can J Urol 2013; 20: 6840-6843
320 Requarth J. Image-guided palliative care procedures. Surg Clin North Am 2011; 91: 367-402, ix
321 Mariani PJ, Setla JA. Palliative ultrasound for home care hospice patients. Acad Emerg Med 2010; 17: 293-296